Company news
Eledon Pharmaceuticals, Inc. news in 2023
Eledon Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
November 8, 2023
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
November 1, 2023
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
October 22, 2023
Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting
October 12, 2023
Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors
October 1, 2023
Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human
September 24, 2023
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
September 10, 2023
Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates
September 5, 2023
Eledon Pharmaceuticals Announces First Participant Dosed in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Rejection in Kidney Transplantation
September 4, 2023
Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation
August 15, 2023
Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results
August 9, 2023
Eledon Pharmaceuticals Reports First Quarter 2023 Operating and Financial Results
May 10, 2023
Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
May 3, 2023
Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
April 30, 2023
Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology
March 30, 2023
Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results
March 29, 2023
Eledon to Present Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation at the World Congress of Nephrology 2023
March 22, 2023
Eledon Pharmaceuticals Provides Business and Pipeline Updates
January 8, 2023
Calls in 2023
Decks in 2023
- Technical Presentation (November 2023)
Technical · 15 slides · Nov 2, 2023
- Investor Presentation (January 2023)
Investor deck · 25 slides · Jan 9, 2023